For laboratory research use only. Not for human or veterinary use. Sold to qualified researchers 21+. Research-use terms

Free standard shipping on orders $99+ Shop →

Compound reference

ARA-290 (cibinetide) CAS, molecular weight and sequence: identity reference

By · Published · updated · vendor-authored explanatory note

Short answer

ARA-290 (cibinetide, also called pyroglutamate helix B surface peptide or pHBSP) is the synthetic 11-residue peptide pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser with a free C-terminal acid. PubChem CID 91810664 lists CAS 1208243-50-8, formula C51H84N16O21, an average molecular weight of 1257.3 g/mol and a monoisotopic mass of 1256.5997 Da, so LC-MS identity checks look for [M+H]+ at m/z 1257.61 and [M+2H]2+ at m/z 629.31. Research-grade ARA-290 from this catalog is for laboratory research use only.

View research-grade ARA-290 in the catalog

ARA-290 identity data from PubChem CID 91810664 (retrieved 2026-11-20). Ion values are calculated from the monoisotopic mass, not measured on any lot.
PropertyValueNote
CAS number1208243-50-8From the PubChem synonym list of CID 91810664. Salt forms are the same peptide plus counter-ions.
PubChem CID91810664Record title: Cibinetide. Synonyms include ARA290, ARA-290, pHBSP and UNII 9W5677JKDA.
Molecular formulaC51H84N16O21Free peptide, no counter-ions.
Average molecular weight1257.3 g/molUse for mg-to-mole arithmetic.
Monoisotopic mass1256.5997 DaUse for high-resolution MS.
Sequence (11 residues)pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser-OH (one-letter: pEEQLERALNSS)pGlu = pyroglutamic acid (5-oxoproline); free C-terminal acid, not an amide.
Expected ESI ions (calc.)[M+H]+ m/z 1257.61; [M+2H]2+ m/z 629.31; [M−H]− m/z 1255.59Arg is the only strongly basic site, so 1+ and 2+ dominate in positive mode.
Net charge at pH 7 (approx.)−2Two Glu side chains and the C-terminal carboxylate against one Arg; the pGlu N-terminus carries no charge.
Aromatic residuesNoneNo Trp, Tyr or Phe, so HPLC detection relies on the peptide bond (about 214 nm), not 280 nm.

Identifiers that should match on a purchase order

For analytical procurement the durable identifiers are CAS 1208243-50-8, formula C51H84N16O21 and an average mass of 1257.3 g/mol. PubChem CID 91810664 is the public structure record behind those numbers, and its synonym list ties together the names you will see on documents: cibinetide, ARA290 / ARA-290 and pHBSP.

The catalog product data on this site lists the same CAS, formula and 1,257.3 g/mol. Write the salt form on the order too, because counter-ions add weight to the powder without adding peptide.

  1. CAS 1208243-50-8 and the name ARA-290 / cibinetide on the PO and receiving log.
  2. Formula C51H84N16O21 and MW 1257.3 g/mol (free peptide) on the analytical worksheet.
  3. Salt form and the lot number printed on the vial.

Where the sequence comes from

Brines and co-workers (PNAS 2008) described ARA-290 as an 11-amino-acid peptide built from residues that sit next to each other on the solvent-facing side of helix B of erythropoietin (helix B spans residues 58-82 of the mature protein). The residues are neighbours in the folded structure, not in the linear chain, so the sequence EQLERALNSS does not appear as one continuous stretch in the erythropoietin precursor (UniProt P01588). A database search of the precursor for this string will come back empty; that is expected and is not an identity problem.

Because ARA-290 is a short linear peptide rather than a fragment of a recombinant protein, it is made by solid-phase synthesis, and its impurity profile looks like that of other synthetic 10-15-mers: deletion sequences, incomplete N-terminal cyclization and deamidation products.

The pyroglutamate N-terminus and the mass shifts it causes

The first residue is pyroglutamic acid, the five-membered lactam formed when an N-terminal glutamine (losing NH3) or glutamic acid (losing H2O) cyclizes. Chelius et al. (Anal Chem 2006) characterised the same cyclization on proteins and showed it is easy to see by mass. For ARA-290 it means the N-terminus has no free amine, which also blocks classical Edman sequencing from the N-terminus; MS/MS is the practical sequence check.

On an LC-MS report, these shifts from the expected [M+H]+ of m/z 1257.61 are the useful ones to recognise:

  1. +17.03 Da: open-chain N-terminal Gln (cyclization incomplete).
  2. +18.01 Da: open-chain N-terminal Glu instead of pGlu.
  3. +0.98 Da: deamidation at Asn9 or Gln3 (MS/MS is needed to place it).
  4. −87.03 Da: a missing serine (des-Ser deletion).
  5. +21.98 Da: sodium adduct, an ionisation artefact rather than an impurity.

HPLC notes for an acidic peptide with no aromatic residues

ARA-290 carries about −2 net charge at neutral pH and has no aromatic side chains, so it is fairly polar and gives little signal at 280 nm. A useful HPLC report for this compound states the column, both mobile phases, the gradient, the detection wavelength (typically in the 210-220 nm range for the peptide bond) and the integration rule behind the area-percent purity.

The open-chain Gln variant and deamidated forms usually sit close to the main peak, so a method that has been shown to separate them (or an LC-MS run with extracted-ion traces at m/z 1257.61 and 1274.63) is what makes a purity figure meaningful.

Lot documentation and ordering

No third-party lot report for ARA-290 is published on this site yet. A lab report is available on request for the lot you would receive, and the batch number on the vial can be checked on the lot lookup page. Only some lots have a published COA.

Self-serve orders from the United States (Canada and Mexico are paused) use US fulfillment and usually ship within 5 business days of confirmed payment. Credentialed laboratories in other eligible countries can request an institutional export review through the international lab orders page.

Frequently asked

What is the CAS number of ARA-290 (cibinetide)?

1208243-50-8, per PubChem CID 91810664 (retrieved 2026-11-20).

What is the molecular weight of ARA-290?

1257.3 g/mol average (C51H84N16O21, free peptide) and 1256.5997 Da monoisotopic, per PubChem. Salt forms weigh more per mole of peptide.

What is the ARA-290 sequence?

pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser with a free C-terminal acid (one-letter pEEQLERALNSS), where pGlu is pyroglutamic acid.

Which ions confirm ARA-290 identity by LC-MS?

[M+H]+ at m/z 1257.61 and [M+2H]2+ at m/z 629.31 in positive mode, or [M−H]− at m/z 1255.59 in negative mode (all calculated). A peak 17.03 Da heavier points to an uncyclized N-terminal Gln.

Why can't I find the ARA-290 sequence inside erythropoietin?

Its residues are neighbours on the folded surface of helix B, not a continuous run in the linear chain, so a substring search of UniProt P01588 returns nothing.

Is there a published COA for ARA-290 on this site?

Not yet. Only some lots have a published report. A lab report is available on request for the specific lot, and batch numbers can be checked on the lot lookup page.

Is research-grade ARA-290 a finished drug?

No. It is sold for laboratory research use only and is not for human or veterinary consumption.

References

  1. PubChem: Cibinetide (CID 91810664)CAS 1208243-50-8, C51H84N16O21, 1257.3 g/mol, monoisotopic 1256.5997 Da, synonyms ARA290 / pHBSP / pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser (retrieved 2026-11-20).
  2. UniProt P01588: Erythropoietin (EPO), Homo sapiensPrecursor sequence and helix annotations for the parent protein; used to confirm the ARA-290 sequence is not a contiguous fragment (retrieved 2026-11-20).
  3. Brines M et al. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci U S A 2008;105(31):10925-30 (PMID 18676614)Original description of the 11-residue peptide built from the solvent-facing residues of erythropoietin helix B (residues 58-82).
  4. Chelius D et al. Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem 2006;78(7):2370-6 (PMID 16579622)Analytical chemistry of N-terminal pyroglutamate formation and how it is detected by mass.